Financial Counselors Inc. trimmed its position in shares of Cabot Co. (NYSE:CBT – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,602 shares of the specialty chemicals company’s stock after selling 140 shares during the period. Financial Counselors Inc.’s holdings in Cabot were worth $877,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. R Squared Ltd bought a new stake in shares of Cabot in the 4th quarter valued at about $26,000. EverSource Wealth Advisors LLC raised its stake in Cabot by 37.2% in the fourth quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock valued at $74,000 after buying an additional 219 shares during the period. GAMMA Investing LLC lifted its position in shares of Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock valued at $123,000 after buying an additional 130 shares during the last quarter. Manchester Capital Management LLC boosted its stake in shares of Cabot by 1,685.1% during the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company’s stock worth $153,000 after acquiring an additional 1,584 shares during the period. Finally, KBC Group NV raised its stake in Cabot by 43.1% in the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock valued at $187,000 after acquiring an additional 616 shares during the period. 93.18% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have commented on CBT. Mizuho reduced their price objective on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research report on Tuesday, January 7th. JPMorgan Chase & Co. decreased their price target on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. Finally, StockNews.com downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research report on Tuesday, March 11th. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $97.00.
Cabot Trading Up 0.7 %
Shares of Cabot stock opened at $84.14 on Friday. Cabot Co. has a 52-week low of $79.57 and a 52-week high of $117.46. The stock has a market cap of $4.56 billion, a PE ratio of 11.17, a PEG ratio of 0.74 and a beta of 1.21. The firm has a 50-day moving average of $85.90 and a 200-day moving average of $98.31. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00.
Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. As a group, sell-side analysts forecast that Cabot Co. will post 7.57 EPS for the current year.
Cabot Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.04%. Cabot’s payout ratio is 22.84%.
Cabot declared that its Board of Directors has approved a share buyback program on Tuesday, December 3rd that authorizes the company to repurchase 10,000,000 outstanding shares. This repurchase authorization authorizes the specialty chemicals company to buy shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its shares are undervalued.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
See Also
- Five stocks we like better than Cabot
- What is MarketRank™? How to Use it
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Quiet Period Expirations Explained
- Top 3 Beverage Stocks Pouring Out Profits
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.